Understanding the Clinical Trial Process MStranslate April 26, 2016 Research, Understanding Science By Brett Drummond When we talk about basic science discoveries related to multiple sclerosis, we often finish the article by explaining that this...
Interview: Dr Rebecca Spain – AAN Meeting 2016 MStranslate April 21, 2016 AAN, Conferences, Research, Treatments 1 Comment AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND...
Interview: Dr Tomas Kalincik – AAN Meeting 2016 MStranslate April 19, 2016 AAN, Conferences, Research AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR TOMAS KALINCIK – MELBOURNE BRAIN CENTRE, ROYAL MELBOURNE...
Antihistamine may stimulate myelin repair MStranslate April 13, 2016 Clinical Trials, Remyelination, Research, Treatments 1 Comment A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially...
Stem Cell Culture Media Improves EAE MStranslate April 11, 2016 Research, Stem Cells, Treatments Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune...
Gut Microbiome Alters Myelination MStranslate April 6, 2016 Research, Treatments Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus...
Rituximab vs Fingolimod in JCV+ Individuals MStranslate April 5, 2016 Fingolimod, Natalizumab, Research, Rituximab Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as...
Rehearse then Research – By Brett Drummond MStranslate April 1, 2016 Opinion, Research An MStranslate Opinion Piece When I was younger, I was cast in the role of Robin Hood in a school musical. I robbed from the rich to give to the...
Can Plant Peptides Treat Multiple Sclerosis? MStranslate March 31, 2016 Research Research Summary: Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis The background When developing new...
Natalizumab, B cells and Multiple Sclerosis MStranslate March 29, 2016 B Cells, Basic Sciences, Natalizumab, Research, Treatments Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The...
